Participants in a guided peer support group had significantly fewer negative symptoms of psychosis.

More info: An 8 month randomized controlled study compared GPSG (Guided Peer Support Groups) with a wait-list condition (WLC). Patients had a clinical diagnosis of schizophrenia or a related psychotic disorder and were 18 years of age or older. All outcomes were self-reported, and were measured before the group started and after the last meeting at 8 months. From the source: “In fact, the participants in the experimental condition had...

Read More

85% of participants in a guided peer support group reported that the group fulfilled their expectations.

More info: An 8 month randomized controlled study compared GPSG (Guided Peer Support Groups) with a wait-list condition (WLC). Patients had a clinical diagnosis of schizophrenia or a related psychotic disorder and were 18 years of age or older. All outcomes were self-reported, and were measured before the group started and after the last meeting at 8 months. From the source: “Almost all participants (85%) reported that the intervention...

Read More

Involvement with peer mentors is associated with better social functioning and community adjustment.

More info: 60 individuals with a mental health diagnosis of “schizophrenia,” “schizoaffective disorder,” or “bipolar disorder” and at least one psychiatric hospitalization were followed for 7 months. Social functioning and employment of problem-centered coping strategies were higher amongst those who participated in peer-run programs and self-help groups than amongst people who received only services as usual from their Community...

Read More

A schizophrenia study from the 1970s showed those treated with psychosocial care and limited use of antipsychotics had a lower relapse rate and earlier discharge date than those who received psychiatric treatment-as-usual with a neuroleptic.

More info: 80 young men diagnosed with “schizophrenia” were followed for 3 years.  Those treated without drugs were discharged sooner than participants who received the neuroleptic (chlorpromazine), and only 35% of those treated without drugs experienced relapse within a year of discharge.  45% of those treated with the neuroleptic  experienced relapse. From the source: “This study indicates that among young acute schizophrenic males...

Read More